Articles published by Amneal Pharmaceuticals, Inc.
![](https://mms.businesswire.com/media/20240711590201/en/1956686/22/AMRX_Logo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240709436382/en/1956686/22/AMRX_Logo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240701356353/en/1956686/22/AMRX_Logo.jpg)
![](https://mms.businesswire.com/media/20240628679742/en/1956686/22/AMRX_Logo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240605270382/en/1956686/22/AMRX_Logo.jpg)
![](https://mms.businesswire.com/media/20240522229390/en/1956686/22/AMRX_Logo.jpg)
![](https://mms.businesswire.com/media/20240522763089/en/1956686/22/AMRX_Logo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240503325618/en/1956686/22/AMRX_Logo.jpg)
![](https://mms.businesswire.com/media/20240424236083/en/1956686/22/AMRX_Logo.jpg)
![](https://mms.businesswire.com/media/20240416056001/en/1956686/22/AMRX_Logo.jpg)
![](https://mms.businesswire.com/media/20240410515765/en/1956686/22/AMRX_Logo.jpg)
Amneal to Report First Quarter 2024 Results on May 3, 2024
April 10, 2024
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240328005176/en/1956686/22/AMRX_Logo.jpg)
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
March 28, 2024
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240325695019/en/1956686/22/AMRX_Logo.jpg)
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
March 25, 2024
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240301034971/en/1956686/22/AMRX_Logo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240227147740/en/1956686/22/AMRX_Logo.jpg)
Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203
February 27, 2024
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240213680899/en/1956686/22/AMRX_Logo.jpg)
Amneal to Participate at Upcoming Investor Conference
February 13, 2024
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240131859245/en/1956686/22/AMRX_Logo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240110374733/en/1956686/22/AMRX_Logo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20240104298091/en/1956686/22/AMRX_Logo.jpg)
Amneal Launched Record Number of 39 New Retail and Injectable Products in 2023, Including 13 in Q4 2023
January 04, 2024
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20231221596021/en/1956686/22/AMRX_Logo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20231215574199/en/1956686/22/AMRX_Logo.jpg)
![](https://mms.businesswire.com/media/20231207320607/en/1962295/22/BIAL_Logo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20231201265945/en/1956684/22/image001%5B47%5D.jpg)
Via Business Wire
Tickers
AMRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Amneal Reports Third Quarter 2023 Financial Results
November 07, 2023
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20231103084537/en/1932090/22/amneal_logo_Logo.jpg)
Amneal to Participate at Upcoming Investor Conferences
November 03, 2023
Via Business Wire
Tickers
AMRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Amneal Adds Two Denosumab Biosimilars to U.S. Pipeline, Expanding Oncology Portfolio
October 12, 2023
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20231005750308/en/1903088/22/AMRX_Logo.jpg)
Amneal to Report Third Quarter 2023 Results on November 7, 2023
October 05, 2023
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230906918972/en/803761/5/amneallogo.jpg)
Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection
September 06, 2023
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230906340098/en/803761/5/amneallogo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.